AVDR - Biotech Stocks Hitting the Public Market This Year: Best Ones to Watch

Last year was a record year for biotech stocks, with an impressive number of companies going public and raising a significant amount of money in the space. In fact, in 2018 there were 80 biotech IPOs that raised a record total of $8.65 billion in gross proceeds.

This trend is continuing into 2019, as more and more biotech stocks announce IPOs and hit the public market. Of the companies going public, many are focused on the treatment of cancer, while a couple have been developing drugs to treat Alzheimer’s disease.

In fact, the global ...